title: Accentuated vagal antagonism of beta-adrenergic effects on ventricular repolarization. Evidence of weaker antagonism in hostile type A men.
abstract: BACKGROUND
  Prior research has suggested a weaker parasympathetic antagonism of sympathetic effects on the heart in type A (coronary-prone) men. To confirm this phenomenon and extend our understanding of it, we investigated the effects of prior muscarinic blockade on the electrocardiogram T wave and other cardiovascular and neuroendocrine responses to isoproterenol in type A and type B (non-coronary-prone) men.
  
  
  RESULTS
  Responses to two 5-minute intravenous isoproterenol infusions (0.01 micrograms/kg/min and 0.02 micrograms/kg/min) were evaluated in six type A and six type B men after pretreatment with either dextrose placebo or atropine (1.2 mg). Atropine significantly potentiated T wave attenuation in the recovery period after isoproterenol infusion (0.30 +/- 0.07 mV) compared with placebo (0.54 +/- 0.09 mV, p less than 0.001). Atropine also potentiated the heart rate increase to isoproterenol (39 +/- 3 beats per minute versus 20 +/- 2 beats per minute after placebo). Atropine enhanced decreases in systolic, diastolic, and mean arterial pressures as well as pulse pressure to isoproterenol. Atropine enhancement of many of these responses was increased among subjects with high scores on various hostility/anger scales. Isoproterenol alone produced greater T wave attenuation in type A than in type B men. However, atropine enhancement of T wave attenuation and blood pressure falls by isoproterenol was present only in type B men.
  
  
  CONCLUSIONS
  These findings indicate that there is accentuated parasympathetic antagonism of T wave attenuation and blood pressure responses induced by beta-adrenergic stimulation. Relative weakness of this antagonism of sympathetic effects on the heart in hostile type A individuals may contribute to their higher coronary disease risk.
authors.affiliation: Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC 27710.
authors.forename: S
authors.initials: S
authors.lastname: Fukudo
authors.forename: J D
authors.initials: JD
authors.lastname: Lane
authors.forename: N B
authors.initials: NB
authors.lastname: Anderson
authors.forename: C M
authors.initials: CM
authors.lastname: Kuhn
authors.forename: S M
authors.initials: SM
authors.lastname: Schanberg
authors.forename: N
authors.initials: N
authors.lastname: McCown
authors.forename: M
authors.initials: M
authors.lastname: Muranaka
authors.forename: J
authors.initials: J
authors.lastname: Suzuki
authors.forename: R B
authors.initials: RB
authors.lastname: Williams
mesh_terms: D000328:Adult; D001285:Atropine / Q000494:pharmacology; D004562:Electrocardiography; D006321:Heart / Q000294:innervation*; D006339:Heart Rate / Q000502:physiology; D006791:Hostility; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D011292:Premedication; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014434:Type A Personality; D014630:Vagus Nerve / Q000502:physiology*
chemical_list: D011943:Receptors, Adrenergic, beta; D001285:Atropine; D007545:Isoproterenol